An Analysis of the Generic Pharmaceutical Industries in ...

After the TRIPS Agreement came into force on January 1, 1995, countries were granted different time frames for compliance based on economic and financial reasons. Article 65 dictated that all developed members had one year (1996, if membership began in 1995) to amend their patent legislation whereas developing members had five years (until 2000 ... ................
................